Oral and intravenous pharmacokinetics of 5-fluoro-2′-deoxycytidine and THU in cynomolgus monkeys and humans

被引：0
|
作者：
Julianne L. Holleran
Jan H. Beumer
David L. McCormick
William D. Johnson
Edward M. Newman
James H. Doroshow
Shivaani Kummar
Joseph M. Covey
Myrtle Davis
Julie L. Eiseman
机构：
[1] University of Pittsburgh,Cancer Therapeutics Program, University of Pittsburgh Cancer Institute
[2] University of Pittsburgh,Department of Pharmaceutical Sciences, School of Pharmacy
[3] University of Pittsburgh,Department of Medicine, School of Medicine
[4] IIT Research Institute,Department of Cancer Biology
[5] City of Hope Beckman Research Institute,Division of Cancer Treatment and Diagnosis
[6] NCI,Department of Pharmacology and Chemical Biology, School of Medicine
[7] NIH,undefined
[8] University of Pittsburgh,undefined
[9] University of Pittsburgh Cancer Institute,undefined
[10] University of Pittsburgh Cancer Institute,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Fluorodeoxycytidine; Tetrahydrouridine; Toxicokinetics; Toxicity; Monkeys; DNA methylation inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：803 / 811
页数：8
相关论文
共 50 条
  • [1] Oral and intravenous pharmacokinetics of 5-fluoro-2′-deoxycytidine and THU in cynomolgus monkeys and humans
    Holleran, Julianne L.
    Beumer, Jan H.
    McCormick, David L.
    Johnson, William D.
    Newman, Edward M.
    Doroshow, James H.
    Kummar, Shivaani
    Covey, Joseph M.
    Davis, Myrtle
    Eiseman, Julie L.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 803 - 811
  • [2] Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine in mice
    Beumer, Jan H.
    Eiseman, Julie L.
    Parise, Robert A.
    Joseph, Erin
    Holleran, Julianne L.
    Covey, Joseph M.
    Egorin, Merrill J.
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (24) : 7483 - 7491
  • [3] Stability of 5-Fluoro-2′-deoxycytidine and Tetrahydrouridine in Combination
    Guo, Duoli
    Myrdal, Paul B.
    Karlage, Kelly L.
    O'Connell, Sean P.
    Wissinger, Travis J.
    Tabibi, S. Esmail
    Yalkowsky, Samuel H.
    [J]. AAPS PHARMSCITECH, 2010, 11 (01): : 247 - 252
  • [4] SYNTHESIS OF OLIGODEOXYRIBONUCLEOTIDES CONTAINING 5-FLUORO-2'-DEOXYCYTIDINE
    KUBAREVA, EA
    ROMANOVA, EA
    ORETSKAYA, TS
    GROMOVA, ES
    SHABAROVA, ZA
    [J]. BIOORGANICHESKAYA KHIMIYA, 1992, 18 (05): : 748 - 750
  • [5] Stability of 5-Fluoro-2′-deoxycytidine and Tetrahydrouridine in Combination
    Duoli Guo
    Paul B. Myrdal
    Kelly L. Karlage
    Sean P. O’Connell
    Travis J. Wissinger
    S. Esmail Tabibi
    Samuel H. Yalkowsky
    [J]. AAPS PharmSciTech, 2010, 11 : 247 - 252
  • [6] ON THE INHIBITION OF DEOXYCYTIDYLATE HYDROXYMETHYLASE BY 5-FLUORO-2'-DEOXYCYTIDINE 5'-MONOPHOSPHATE
    SUBRAMANIAM, R
    WANG, Y
    MATHEWS, CK
    SANTI, DV
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1989, 275 (01) : 11 - 15
  • [7] CHEMICAL SYNTHESIS OF 2'-DEOXYOLIGONUCLEOTIDES CONTAINING 5-FLUORO-2'-DEOXYCYTIDINE
    SCHMIDT, S
    PEIN, CD
    FRITZ, HJ
    CECH, D
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (10) : 2421 - 2426
  • [8] Phase I trial of oral 5-fluoro-2′-deoxycytidine with oral tetrahydrouridine in patients with advanced solid tumors
    Coyne, G. O'Sullivan
    Chen, A. P.
    Kummar, S.
    Meehan, R. S.
    Collins, J.
    Zlott, J.
    Kelly, K.
    Lenz, H. J.
    Newman, E. M.
    Morgan, R.
    Juwara, L.
    Eiseman, J.
    Beumer, J. H.
    Tomaszewski, J.
    Doroshow, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 69 : S90 - S90
  • [9] DISTURBANCES IN FETAL CHONDROGENESIS INDUCED BY 5-FLUORO-2'-DEOXYCYTIDINE IN MICE
    KLEINEBR.J
    SVEJCAR, J
    DEGENHAR.KH
    [J]. TERATOLOGY, 1971, 4 (04) : 491 - &
  • [10] A CONVENIENT METHOD FOR THE DIRECT INCORPORATION OF 5-FLUORO-2'-DEOXYCYTIDINE INTO OLIGODEOXYNUCLEOTIDES
    MARASCO, CJ
    SUFRIN, JR
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (23): : 6363 - 6365
12345